During the Arm vs. Qualcomm court case, Qualcomm's CEO shared how the decision to purchase Nuvia for $1.4 billion was justified to the board.

The chief executive of Arm (O9Ty.F) has downplayed the company's ambitions to become a chip supplier in its own right at a trial against Qualcomm, a major customer that pays Arm an estimated hundreds of millions of dollars per year.

In a high-stakes trial unfolding in US federal court in Delaware, former Apple executive Gerard Williams III took the stand to address a crucial question: Who

Internal Qualcomm documents showed the chip firm estimated it could eventually save as much as $1.4 billion a year on payments to Arm by purchasing a little-known startup in 2021, according to evidence shown at a trial on Wednesday.

In 2022, Arm ignited a legal battle after Qualcomm continued to pay its existing royalty fees to Arm, which were allegedly much lower than what Nuvia was paying. After the two failed to come to an agreement, Arm argued the designs licensed to Nuvia were no longer valid, and that Qualcomm should destroy the technology created with them.

Qualcomm's central processors are properly licensed under an agreement with Arm Holdings, a jury found in a trial in U.S. federal court that removed some, but not all, uncertainty around the mobile chipmaker's expansion into the laptop market.

Qualcomm Inc. prevailed at trial against Arm Holdings Plc’s claim that it breached a license for chip technology that the world’s largest maker of mobile-phone processors acquired when it bought a startup in 2021.

A federal jury in the United States on Friday delivered a key win to mobile commputing titan Qualcomm in a licensing dispute with Arm, although proceedings between the chipmakers ended in mistrial.

Arm Holdings' lawsuit against Qualcomm ended on Friday with a jury delivering a mixed verdict that found for Qualcomm on a crucial issue, saying Qualcomm had properly licensed its central processor chips.